Colorado State University — Biomedical Watch V2

Traitements9programmes

Essais6liés

Publications0liées

SourceDBlocale

Traitements

9

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1/2	À vérifier	United States	À vérifier
Aminophylline+MethazolamideIn low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.	SEP	Phase 1/2	À vérifier	United States	À vérifier
MethazolamideThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1/2	À vérifier	United States	À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1	À vérifier	United States	À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Non applicable	À vérifier	United States	À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 4	À vérifier	Egypt	À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1	À vérifier	United States	À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1	À vérifier		À vérifier
AminophyllineThis safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.	SEP	Phase 1/2	À vérifier	United States	À vérifier

Essais cliniques

6

Molécule	Indication / population	Phase	NCT	Titre	Statut
Aminophylline	SEP	Phase 1/2	NCT01702025	Rapid Acclimatization to Hypoxia at Altitude	COMPLETED
Aminophylline	SEP	Phase 1	NCT02983422	Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient	UNKNOWN
Aminophylline	SEP	Phase 1	NCT01530464	GQ01 — The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers	COMPLETED
Aminophylline	SEP	Phase 4	NCT05552404	Postdural Puncture Headache Relief With Aminophylline and SPGB	COMPLETED
Aminophylline	SEP	Non applicable	NCT01245595	KIDPROAM — Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery	COMPLETED
Aminophylline	SEP	Phase 1	NCT01587027	Safety Evaluation of Aminophylline and Methazolamide	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.